To completely prove that ADAR2 contributes to the protective effect of NAFLD via regulating miR-34a as key molecules generated by exercise, further study is required to carry out in vivo research in mice and is required to evaluate the effect of ADAR2 as a therapeutic method for NAFLD. This evidence concerns the gene ADARB1 and metabolic dysfunction-associated steatotic liver disease.